Sharps Technology (NASDAQ: STSS) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders.
STSS and The Tie announce a strategic collaboration to strengthen Solana's institutional infrastructure. STSS will delegate a portion of its 2+ million SOL treasury to Stakin by The Tie and participate in institutional events including Innovate Miami, Out East Summit, and The Bridge.
Read moreSTSS and BitGo announce a strategic collaboration to expand and institutionalize STSS's Solana treasury strategy through BitGo's qualified custody, Solana staking validator, and OTC trading services.
Read moreSTSS announces the expansion of its relationship with Coinbase Institutional through the launch of a jointly supported institutional-grade validator on the Solana network. STSS will delegate a portion of its SOL treasury holdings, currently more than 2 million SOL, to its newly established Coinbase-operated validator.
Read moreSTSS announces Q3 2025 financial results, highlighting $411 million PIPE financing, over 2.0 million SOL in treasury, $17.7 million in combined staking revenue and digital-asset gains, and successful completion of strategic exit from legacy manufacturing operations.
Read moreSTSS announces strategic collaboration with Coinbase Global, Inc. to expand its Solana digital asset treasury strategy. The Company has acquired over 2 million SOL to-date, valued at over $400 million, and will utilize Coinbase Prime's custody infrastructure and OTC desk products.
Read moreSTSS announces strategic stock repurchase program to acquire up to $100 million of outstanding common stock, demonstrating confidence in long-term growth prospects while continuing execution of its Solana digital asset treasury strategy.
Read moreSharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. Sharps Technology also offers products that are designed with specialized copolymer technology to support the pre-fillable syringe market segment. The Company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. Sharps Technology will provide access to the Solana network, the fastest and most used blockchain in the world.
Subscribe to receive the latest investor news, financial reports, and company announcements directly to your inbox.